| 000 | 01842 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250512022748.0 | ||
| 264 | 0 | _c19850710 | |
| 008 | 198507s 0 0 eng d | ||
| 022 | _a0735-1097 | ||
| 024 | 7 |
_a10.1016/s0735-1097(85)80361-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKern, M J | |
| 245 | 0 | 0 |
_aRegional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery disease. _h[electronic resource] |
| 260 |
_bJournal of the American College of Cardiology _cJun 1985 |
||
| 300 |
_a1438-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xpharmacology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 | _aCold Temperature |
| 650 | 0 | 4 |
_aCollateral Circulation _xdrug effects |
| 650 | 0 | 4 |
_aCoronary Circulation _xdrug effects |
| 650 | 0 | 4 |
_aCoronary Disease _xdrug therapy |
| 650 | 0 | 4 |
_aCoronary Vessels _xdrug effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmersion |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aNifedipine _xpharmacology |
| 650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
| 650 | 0 | 4 |
_aPropranolol _xpharmacology |
| 650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
| 650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
| 700 | 1 | _aPetru, M A | |
| 700 | 1 | _aFerry, D R | |
| 700 | 1 | _aEilen, S D | |
| 700 | 1 | _aBarr, W K | |
| 700 | 1 | _aPorter, C B | |
| 700 | 1 | _aO'Rourke, R A | |
| 773 | 0 |
_tJournal of the American College of Cardiology _gvol. 5 _gno. 6 _gp. 1438-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0735-1097(85)80361-2 _zAvailable from publisher's website |
| 999 |
_c2865994 _d2865994 |
||